Quote:
nice find brentie. This is a short (2:37) video which was just posted yesterday of Dr. Jay discussing CCR5.
Here is the youtube description:
Jay Lalezari, CEO of CytoDyn, explains how the CCR5 receptor has emerged as a pivotal target in metastatic cancers due to its dual role in promoting tumor cell migration and shaping a protective tumor microenvironment.
Newer stockholders will enjoy not only the message, but watching our CEO.